Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 18.51 USD 5.65% Market Closed
Market Cap: $1.3B
Write Note Create Alert Ask AI

Profitability Summary

MoonLake Immunotherapeutics's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
MoonLake Immunotherapeutics

Margins Comparison
MoonLake Immunotherapeutics Competitors

Country Company Market Cap Operating
Margin 		Net
Margin
CH
MoonLake Immunotherapeutics
NASDAQ:MLTX
1.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.6B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44.4B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
43.8B USD
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
291.5B CNY
Loading...
Loading...
DE
BioNTech SE
NASDAQ:BNTX
25.9B USD
Loading...
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
20.3B USD
Loading...
Loading...
US
Incyte Corp
NASDAQ:INCY
20.4B USD
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
19.6B USD
Loading...
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
18.9B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
MoonLake Immunotherapeutics Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
MoonLake Immunotherapeutics
NASDAQ:MLTX
1.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
43.8B USD
Loading...
Loading...
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
291.5B CNY
Loading...
Loading...
Loading...
Loading...
DE
BioNTech SE
NASDAQ:BNTX
25.9B USD
Loading...
Loading...
Loading...
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
20.3B USD
Loading...
Loading...
Loading...
Loading...
US
Incyte Corp
NASDAQ:INCY
20.4B USD
Loading...
Loading...
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
19.6B USD
Loading...
Loading...
Loading...
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
18.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
MoonLake Immunotherapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate

See Also

Summary
MLTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MLTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MLTX stock valuation using valuation multiples.
Wall Street Estimates
MLTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MLTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.